Omny-IRE data demonstrated the investigational OMNYPULSE™ Platform achieved 100% acute success and 84.5% pulmonary vein isolation (PVI) durability at three months, with promising safety outcomes1 Additional data presented from VARIPURE registry2 and Dual Energy THERMOCOOL SMARTTOUCH™ SF...
Hence then, the article about johnson johnson medtech presents 3 month data from omny ire clinical trial at 2025 heart rhythm society annual meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Johnson & Johnson MedTech Presents 3-Month Data from Omny-IRE Clinical Trial at 2025 Heart Rhythm Society Annual Meeting )
Also on site :
- Kevin Warsh’s first big press conference shines a spotlight on confusion over how the Fed actually measures inflation
- The Lenox Spice Village Trend Is Back, and Macy's ‘Vibrant’ Matching Table Linens Are a ‘Beautiful’ Addition
- Amazon may owe you money: It just got $600 million in tariff refunds after a lawsuit accused it of favoring Trump